KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
Nature Aging / 2026-10-14

A different route to cellular reprogramming

Cells + animals · Preclinical benefit

AI-generated cellular concept illustration
Concept illustration · not experimental data

What was reported

An RNA-splicing regulator, SRSF1, emerged from a screen for more youthful transcriptional states. In human fibroblasts, increased expression reduced several senescence-associated features without an observed loss of cell identity. The authors also reported less frailty progression and a 14% extension of median lifespan in a small aged-mouse experiment.

Read the primary source ↗

What the study measured

Cell-state signatures; senescence-associated features; mouse frailty and survival.

Sample and setting

Mouse survival groups: 9–10 animals per group.

What this does not establish

Cells in culture and a small mouse survival experiment are not evidence of human rejuvenation. Durability, dose control, cancer-related risks, and independent replication remain critical questions.

The next question

Can the functional effect be replicated in independent aged-cell systems while preserving cell identity?

This is Karam’s proposed follow-up question, not a claim that the original authors or Karam have already resolved it.

The source record

Transcriptomic reprogramming screen identifies SRSF1 as a regulator of aging

Alexandru M. Plesa, Sascha Jung, et al.
Nature Aging · 2026-10-14

DOI: 10.1038/s43587-026-01234-8

Publisher abstract and data-availability statement checked. Full text and underlying datasets were not independently audited.

Keep exploring

A research question, not a treatment recommendation

What would this evidence change?

Evidence / Scope an engagement

Karam Evidence Sprint

One question. A source trail. A decision you can explain.

Scope & deliverables↗
Evidence / Scope an engagement

Karam Research Watch

Know what changed—not just what was published.

Scope & deliverables↗